Cargando…
Exploring the Antitumor Potential of Copper Complexes Based on Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands
Bis(pyrazol-1-yl)acetic acid (HC(pz)(2)COOH) and bis(3,5-dimethyl-pyrazol-1-yl)acetic acid (HC(pz(Me2))(2)COOH) were converted into the methyl ester derivatives 1 (L(OMe)) and 2 (L(2OMe)), respectively, and were used for the preparation of Cu(I) and Cu(II) complexes 3–10. The copper(II) complexes we...
Autores principales: | Pellei, Maura, Santini, Carlo, Bagnarelli, Luca, Battocchio, Chiara, Iucci, Giovanna, Venditti, Iole, Meneghini, Carlo, Amatori, Simone, Sgarbossa, Paolo, Marzano, Cristina, De Franco, Michele, Gandin, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409343/ https://www.ncbi.nlm.nih.gov/pubmed/36012662 http://dx.doi.org/10.3390/ijms23169397 |
Ejemplares similares
-
Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Management
por: Pellei, Maura, et al.
Publicado: (2023) -
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated
Ligands Designed to Promote Synergistic Antitumor Effects
por: Del Bello, Fabio, et al.
Publicado: (2022) -
Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands
por: Pellei, Maura, et al.
Publicado: (2019) -
Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist
por: Pellei, Maura, et al.
Publicado: (2020) -
A New Dimeric Copper(II) Complex of Hexyl Bis(pyrazolyl)acetate Ligand as an Efficient Catalyst for Allylic Oxidations
por: Bagnarelli, Luca, et al.
Publicado: (2021)